In Alzheimer’s disease, glucose-6-phosphate dehydrogenase (G6PD) and 6-PGD both increase in the cortex [30], suggesting that altered glucose metabolism is associated to the development of neurodegenerative disorders. The gene discussed is G6PD; the disease is early-onset autosomal dominant Alzheimer disease.